CORAL, SANDRA
 Distribuzione geografica
Continente #
EU - Europa 104
AS - Asia 23
NA - Nord America 16
AF - Africa 1
OC - Oceania 1
Totale 145
Nazione #
IT - Italia 48
IE - Irlanda 38
US - Stati Uniti d'America 16
CN - Cina 10
SG - Singapore 5
FI - Finlandia 4
DE - Germania 3
RU - Federazione Russa 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
ES - Italia 2
GB - Regno Unito 2
HK - Hong Kong 2
PH - Filippine 2
AU - Australia 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 145
Città #
Dublin 37
Rome 17
Milan 9
Siena 6
New York 4
Ashburn 3
Catania 3
Helsinki 3
Moscow 3
Shanghai 3
Singapore 3
Abu Dhabi 2
Hong Kong 2
Málaga 2
Brisbane 1
Cascina 1
Florence 1
Hounslow 1
Johannesburg 1
Lambeth 1
Lappeenranta 1
Marino 1
Menderes 1
Novara 1
Oslo 1
Padova 1
Sollentuna 1
Stockholm 1
Turin 1
Vientiane 1
Totale 113
Nome #
A novel microRNA signature for the detection of melanoma by liquid biopsy 43
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 35
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study. 30
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study. 26
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 25
Totale 159
Categoria #
all - tutte 1.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202332 0 0 0 0 5 4 0 2 3 2 14 2
2023/2024124 5 3 14 1 10 20 30 17 11 4 3 6
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 159